4.8 Letter

Letter to the editor: The addition of C-reactive protein and von Willebrand factor to Model for End-Stage Liver Disease-Sodium

Related references

Note: Only part of the references are listed.
Article Oncology

Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas

Mary-Ann El Sharouni et al.

Summary: Although most patients with thin melanomas have a good prognosis, some may experience recurrence. The developed model in this study accurately identifies a subgroup at high risk.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality

Patrick Starlinger et al.

Summary: Adding von Willebrand factor antigen (vWF-Ag) and C-reactive protein (CRP) to the Model for End-Stage Liver Disease-Sodium (MELD-Na) score improves risk stratification of patients awaiting liver transplant, especially in predicting waitlist mortality. The combination of vWF-Ag and CRP provides better predictive value for waitlist mortality, reflecting central pathophysiological mechanisms of portal hypertension, bacterial translocation, and inflammation.

HEPATOLOGY (2021)

Article Oncology

Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study

Andrei Gafita et al.

Summary: Nomograms developed in this study can predict outcomes after Lu-177-PSMA in patients with mCRPC. These predictive models can assist in guiding clinical trial design and individual clinical decision-making, especially in institutions where Lu-177-PSMA is introduced as a novel therapeutic option.

LANCET ONCOLOGY (2021)